These data suggest that enhanced ZAP-70 recruitment at the IS, afforded by the presence of synthetic CXCR4, would enable CAR-CXCR4 NK-92 cells to eliminate lower-antigen-expressing tumor cells. The gene discussed is CXCR4; the disease is neoplasm.